Stressing cells to improve transplant outcomes and cardiac function

Author: Chris Kamel, 07/20/10

There’s a scene in The Simpsons, after Homer suffers from a heart attack, where he paraphrases Friedrich Nietzsche’s famous words, “That which does not kill us makes us stronger.” Those words, in this situation, are overly optimistic. After an ischemic event like a heart attack or a stroke, not only is there massive cell death…Read more

New summary on liver failure and stem cells

Author: Stem Cell Network, 07/15/10

The liver is the largest solid organ in the human body, and performs a critical function in keeping us alive: it removes waste from our bodies, detoxifies our blood, and helps in various other capacities to protect us from harm. Liver disease can severely compromise the liver’s ability to perform its everyday tasks, in part,…Read more

CIHR updates human pluripotent stem cell guidelines

Author: Ubaka Ogbogu, 07/12/10

On June 30, the Canadian Institutes of Health Research (CIHR) released updated Guidelines for Human Pluripotent Stem Cell Research. The Guidelines apply to all research involving human pluripotent stem cells conducted with funding from, or under the auspices of institutions receiving funding from the three federal granting agencies, known as the Tri-Council: CIHR, Natural Sciences…Read more

Personalized medicine is not only a goal, but part of the process, too

Author: Paul Krzyzanowski, 07/08/10

The concept of personalized medicine is an intuitive one: knowing what treatment to provide a patient based on their own individual case of a disease. Molecular techniques and various flavours of “-omics” provide high precision in determining the status and types of many diseases, as well as our susceptibility to them. One key application of…Read more

Can collaboration and commercialization co-exist?

Author: Stem Cell Network, 07/06/10

by Tania Bubela Increasingly, commercialization is a key requirement for securing project funding and support for scientific research. The field of stem cell research is no exception. But does this emphasis on commercialization, which necessarily involves issues of ownership and secrecy, come at the expense of another largely-encouraged element of scientific research, namely academic collaboration?…Read more

Cartilage tissue engineering

Author: Allison Van Winkle, 06/30/10

In the body, cartilage has minimal potential to heal itself once damaged, as the tissue is not naturally exposed to a blood supply, and is then prevented from benefiting from the body’s immune response and wound healing capabilities. By using a tissue engineering approach, researchers hope to develop replacement cartilage that can be transplanted into…Read more

Induced publication of stem cells?

Author: David Kent, 06/28/10

Earlier this month, the New Scientist shook up the stem cell community, putting forth the idea that publication speed, frequency, and journal quality might be skewed by where you’re from and who you know rather than the quality of your data. The article, entitled “Paper trail: Inside the stem cell wars” was inspired by an…Read more

NAS guidelines revised; more turmoil at AHRC

Author: Ubaka Ogbogu, 06/24/10

NAS revises stem cell guidelines: The US National Academy of Sciences recently released amendments to its influential and widely adopted voluntary Guidelines for Human Embryonic Stem Cell Research. This is the third set of amendments since the guidelines were first issued in 2005 (previous amendments were issued in 2007 and 2008). Key revisions include: The…Read more

The hot seat in San Francisco – the last word

Author: Stem Cell Network, 06/19/10

And the last word (or words) goes to Fabio Rossi of the University of British Columbia. So ends a great conference!  

The hot seat in San Francisco – part 4

Author: Stem Cell Network, 06/19/10

Our couch is just too inviting… more comments on ISSCR 2010 from Mike Kallos of the University of Calgary and Feodor Price of the Ottawa Hospital Research Institute.